Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018
Collaborator: Medtronic
Authors: Debroucker F, Delporte L, Ullmann E
In 2015, there was approximately 370 000 type 1 diabetic patients in France. The ageing population and financial constraints have put a great strain on the French healthcare system. Value-based healthcare (VBHC) is emerging as a possible solution to build a more efficient healthcare system. The objectives are to define and rank the most valued outcomes in medical care for patients affected by type 1 diabetes (T1D) and to better understand patients’ expectations for healthcare organizations and patient support services.